Pharmaceutical monitoring and analysis of a case of severe systemic allergic reaction caused by Wujia shenghua capsules during the postpartum period
- VernacularTitle:1例产褥期使用五加生化胶囊致全身性严重过敏反应的药学监护及分析
- Author:
Mingming ZHAO
1
;
Yiqing YE
1
Author Information
1. Dept. of Pharmacy，Jilin Branch，Women’s Hospital，Zhejiang University School of Medicine，Changchun 130042，China
- Publication Type:Journal Article
- Keywords:
Wujia shenghua capsules;
severe systemic allergic reactions;
pharmaceutical monitoring;
adverse drug reactions
- From:
China Pharmacy
2024;35(19):2422-2425
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To correctly identify and respond to severe systemic allergic reactions caused by Wujia shenghua capsules during the postpartum period， provide a reference for medication use in obstetrics and gynecology departments， and promote rational drug use. METHODS Clinical pharmacists participated in the pharmaceutical monitoring and treatment process for a case of severe systemic allergic reaction after using Wujia shenghua capsules during the postpartum period. They screened the medication used by the patient during hospitalization and evaluated the relationship between the allergic reaction and Wujia shenghua capsules， as well as the possible causes of the reaction. RESULTS & CONCLUSIONS The relationship between severe systemic allergic reactions in the patient and Wujia shenghua capsules is evaluated as “likely related”， suggesting that patients with the allergic constitution should be vigilant when using Wujia shenghua capsules during the postpartum period， and pharmaceutical monitoring should be strengthened to avoid the simultaneous use of drugs with the same mechanism or potential interactions.
